- $89.37m
- $154.45m
- CNY14.95bn
- 58
- 62
- 35
- 50
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 20.86 | ||
| Price to Sales | 0.04 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -90.14% | ||
| Return on Equity | n/a | ||
| Operating Margin | -1.9% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 3,952.05 | 8,203.16 | 12,425.9 | 13,516.7 | 14,948.13 | 15,061 | 16,550 | 52.95% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- January 1st, 1970
- Public Since
- September 12th, 2018
- No. of Employees
- 1,520
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
NASDAQ Global Market- Shares in Issue
- 171,328,644
- Address
- 3-4/F, SHANGHAI, 201203
- Web
- http://gangling.111.com.cn/
- Phone
- +86 2120536666
- Auditors
- Deloitte Touche Tohmatsu Certified Public Accountants LLP
Upcoming Events for YI
Q4 2024 111 Inc Earnings Release
Similar to YI
ADMA Biologics
NASDAQ Global Market
ANI Pharmaceuticals
NASDAQ Global Market
Aquestive Therapeutics
NASDAQ Global Market
Avadel Pharmaceuticals
NASDAQ Global Market
Avidity Biosciences
NASDAQ Global Market
FAQ
What is the 111 share price?
As of Today at 19:00 UTC, shares in 111 are trading at $1.04. This share price information is delayed by 15 minutes.
How has the 111 share price performed this year?
Shares in 111 last closed at $1.04 and the price had moved by -58.43% over the past 365 days. In terms of relative price strength the 111 share price has underperformed the S&P500 Index by -68.86% over the past year.
What are the analyst and broker recommendations for 111?
The overall consensus recommendation for 111 is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the 111 dividend yield?
111 does not currently pay a dividend.
Does 111 pay a dividend?
111 does not currently pay a dividend.
When does 111 next pay dividends?
111 does not currently pay a dividend.
How do I buy 111 shares?
To buy shares in 111 you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of 111?
As of the previous close price of $1.04, shares in 111 had a market capitalisation of $89.37m.
Where are 111 shares listed?
Here are the trading details for 111:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: YI
What kind of share is 111?
Based on an overall assessment of its quality, value and momentum 111 is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a 111 share price forecast for 2024?
The analyst consensus target price for shares in 111 is $5.87. That is 462.59% above the last closing price of $1.04.
Analysts covering 111 currently have a consensus Earnings Per Share (EPS) forecast of CNY2.44 for the next financial year.
Find out moreWhat is the trend in the 111 share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like 111. Over the past six months, its share price has underperformed the S&P500 Index by -15.74%.
As of the last closing price of $1.04, shares in 111 were trading -10.2% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the 111 PE Ratio?
The 111 PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.04.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of 111?
We do not have data on 111's directors